What Petri does

Petri is a Boston-based biotech pre-seed accelerator and founder support platform that was co-founded in February 2020 and is operated under Pillar VC's umbrella. The organization invests pre-seed capital in formation-stage bioengineering companies at the intersection of biology and engineering, and wraps that capital with a tightly integrated suite of services: 1:1 mentorship from experienced biotech operators, membership in a peer-founder community, introductions to corporate venture capital and business development groups, and direct recruiting access to a talent network spanning MIT, Harvard, Imperial College London, Mount Sinai, and other research institutions.

The platform is delivered through five core modules (pre-seed capital, mentorship, peer community, partner/customer connections, and talent recruiting) layered with branded programs including The Dish Summit (an annual virtual conference that drew 800+ attendees at launch), The Wave (a network supporting women and under-represented gender founders in bio), Frequency Bio (a free virtual program for prospective founders), the Petri Podcast, and the Founder Playlist template library. Petri monetizes by taking equity in selected portfolio companies; pricing is not publicly disclosed and there is no traditional fee-for-service or SaaS revenue stream. By the end of its first year, Petri had partnered with 11 companies (50% female-founded or co-founded, all university spinouts) and reached 1,000+ PhDs and postdocs through 25+ university events and a 200+ faculty-lab network.

Petri's competitive position rests on the depth of the Pillar VC ecosystem it draws from — co-founded by the CEOs of Exact Sciences, Ginkgo Bioworks, Iora Health, and 22 Boston companies — and on its operating team, which includes Reshma Shetty (Ginkgo Bioworks co-founder), JP Mangeolle (former President of Sciex/Danaher, 35+ years in life sciences), and Virginia Burger (CEO of portfolio company New Equilibrium Biosciences). The portfolio spans human health therapeutics, sustainable materials, agritech, and food tech, with Matterworks ($6M seed, Dec 2020) and New Equilibrium Biosciences ($10M seed led by RA Capital, Mar 2021) representing the largest disclosed raises. Petri is private, pre-revenue in the conventional sense, and operates with a 1-10 person team.

Name

Petri

Legal name

Petri

Website

https://petri.bio

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

1–10 employees

Short description

Petri is a Boston-based biotech pre-seed accelerator co-founded with Pillar VC that provides formation-stage bioengineering founders with pre-seed capital, mentorship, peer community, talent network access, and corporate venture introductions in exchange for equity.

Ownership category

akta.pro rank

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Marketing or Sales, Operations, Others

Distribution channels1 record

Marketing channels8 records

Core offering

Petri is a biotech pre-seed accelerator that surrounds formation-stage founders at the intersection of biology and engineering with pre-seed capital, mentorship from experienced biotech operators, peer community, introductions to business development and corporate venture partners, and access to top university talent. Selected companies receive a comprehensive support package in exchange for equity, and the platform also runs free community programs such as Frequency Bio (startup exploration) and The Wave (women and under-represented gender founders in bio).

Product overview

Petri is a biotech pre-seed accelerator and support platform that surrounds founders with comprehensive resources to build world-class biotech companies. The offering consists of a unified platform combining pre-seed capital, mentorship from industry experts, peer community network, partner/customer introductions, and talent recruiting access. Additional programs include Frequency Bio (virtual startup exploration), The Wave (women founders support), the Petri Podcast (content series), Founder Playlist (templates and tools), and The Dish Summit (annual conference). The platform is co-founded with Pillar VC and draws on resources from one of the strongest biotech ecosystems in the world, having partnered with 11 companies in its first year.

Differentiator

Problem solved

Functional benefit

Products and services

• Pre-Seed Capital Program
• Founder Mentorship
• Peer Community
• Partner and Customer Connections
• Talent Recruiting Network

Named customers8 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered minor.

• GT LawminorGTM or Marketing PartnerSponsor of The Wave Summit event supporting women founders in bio.
• JPMorganminorGTM or Marketing PartnerSponsor of The Wave Summit event supporting women founders in bio.
• True SearchminorGTM or Marketing PartnerSponsor of The Wave Summit event supporting women founders in bio.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Y Combinator (Bio track): The most prominent global startup accelerator, now operating a dedicated bio track that funds and supports formation-stage biotech founders with capital, mentorship, and investor access — directly comparable to Petri's pre-seed biotech thesis.
• IndieBio: SOSV's biotech accelerator that takes formation-stage biology companies through a structured program with capital and lab infrastructure, mirroring Petri's pre-seed biotech support model, though generally at seed rather than formation stage.
• Curie.Bio: Founder-focused biotech accelerator providing capital, operational support, and investor syndication to early-stage therapeutics and bio companies — overlapping strongly with Petri's target customer and stage.
• MBC Biolabs: Bay Area incubator offering lab space, shared equipment, and a community for early-stage biotech founders, addressing the same formation-stage bioengineering founder as Petri with infrastructure-led support.
• Science Inc. Operating company builder/accelerator that builds and funds early-stage tech and science-driven startups with capital and operational resources, structurally similar to Petri's accelerator-plus-support model.

Broad incumbents

• Alexandria LaunchLabs: Alexandria Real Estate's life science startup platform providing lab space, capital connections, and programming across multiple geographies — a broader incumbent serving overlapping biotech founder customers.
• Johnson & Johnson Innovation – JLabs: Global network of life science incubators providing lab space, mentorship, and corporate venture connectivity to early-stage biotech and medtech startups, comparable as a broad incumbent in the same founder segment.
• Flagship Pioneering: Large biotech origination platform that creates and funds transformative bio companies from scientific hypotheses — a much larger incumbent whose model of 'founder-led bio origination' explicitly overlaps Petri's stated thesis.
• Pillar VC: Petri's parent and primary capital backer; a Boston-based venture firm operating across multiple sectors that also runs direct investments and founder programs — directly comparable as the broader entity Petri operates within.

Others

• Petri Bio (UK-based science venture builder): Independent European science startup studio building biotech ventures; thematically adjacent to Petri's mission of launching bio-led companies from the ground up despite geographic separation.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/petribio
• LinkedInlinkedin.com/company/petribio

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments11 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Petri